Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Oslo, Norway, November 19, 2019 PCI Biotech (OSE:PCIB), a late stage clinical company developing innovative therapeutics that address significant unmet medical needs, today announced that it will...
-
Oslo, Norway, 19 November 2019 - PCI Biotech invites to a presentation of the company's third quarter 2019 results on Wednesday 27 November 2019 at Oslo Cancer Cluster Innovation Park. Time:...
-
Oslo, Norway, November 12, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present...
-
Oslo, Norway, October 28, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present...
-
Stocken Invest AS, a wholly owned company by Lars Viksmoen, has on 18 October 2019 transferred 12,966 shares in PCI Biotech Holding ASA (“PCI Biotech”) to Lars Viksmoen, board member of PCI Biotech,...
-
Oslo, Norway, 9 September 2019. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 40,000 new shares following...
-
Oslo (Norway), 4 September 2019 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1. ...
-
Borkenholm AS has on 29 August 2019 bought 4,000 shares in PCI Biotech Holding ASA ("PCI Biotech") at an average price of NOK 26.90 per share. Borkenholm AS is a related party to board member Hilde...
-
Oslo (Norway), 28 August 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its second quarter and first half 2019 result. Please find enclosed the report and...
-
Oslo, Norway, 20 August 2019 - PCI Biotech invites to a presentation of the company's second quarter and first half 2019 results on Wednesday 28 August 2019 at Oslo Cancer Cluster Innovation Park. ...